1-9 of 9
David M. Woods
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO030: A Novel T-cell Population Expressing the Ectoenzymes CD38 and CD39 is Associated with Melanoma Patient Non-Response to Immunotherapy

Free
Ankita Mitra, David M. Woods, Anjali Rao, Andressa S. Laino, Aidan Winters, Itai Yanai, Pratip K. Chattopadhyay, Jeffrey S. Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (2_Supplement): PO030.
https://doi.org/10.1158/2326-6074.TUMIMM20-PO030
Published: 03 February 2021
View articletitled, Abstract PO030: A Novel T-cell Population Expressing the Ectoenzymes CD38 and CD39 is Associated with Melanoma Patient Non-Response to Immunotherapy
Journal Articles

Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma

Available to Purchase
Erik Yusko, Marissa Vignali, Richard K. Wilson, Elaine R. Mardis, F. Stephen Hodi, Christine Horak, Han Chang, David M. Woods, Harlan Robins, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (3): 458–465.
https://doi.org/10.1158/2326-6066.CIR-18-0226
Published: 01 March 2019
View articletitled, Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma
Open the PDF for Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract A067: PD-1 blockade enhances OX40 expression on regulatory T-cells and decreases suppressive function through induction of phospho-STAT3 signaling

Free
David M. Woods, Rupal Ramakrishnan, Andressa L. Sodré, Anders Berglund, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): A067.
https://doi.org/10.1158/2326-6066.IMM2016-A067
Published: 31 October 2016
View articletitled, Abstract A067: PD-1 blockade enhances OX40 expression on regulatory T-cells and decreases suppressive function through induction of phospho-STAT3 signaling
Journal Articles

Abstract B109: Epigenetic reprogramming of T-cells from metastatic melanoma patients enhances central memory and decreases Th2/Treg phenotypes

Free
Andressa L. Sodre, David M. Woods, Amod Sarnaik, Brian C. Betts, Jeffrey S. Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): B109.
https://doi.org/10.1158/2326-6066.IMM2016-B109
Published: 31 October 2016
View articletitled, Abstract B109: Epigenetic reprogramming of T-cells from metastatic melanoma patients enhances central memory and decreases Th2/Treg phenotypes
Journal Articles

Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity

Free
David M. Woods, Andressa L. Sodre, Karrune Woan, Alejandro Villagra, Amod Sarnaik, Jeffrey Weber, Eduardo M. Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A066.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A066
Published: 03 January 2016
View articletitled, Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity
Journal Articles

Abstract A074: Selective Inhibition of HDAC6 augments T-cell central memory and enhances anti-tumor functions: Implications in TIL therapy

Free
Andressa Sodre Laino, David M. Woods, Amod Sarnaik, Jeffrey Weber, Eduardo M. Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A074.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A074
Published: 03 January 2016
View articletitled, Abstract A074: Selective Inhibition of HDAC6 augments T-cell central memory and enhances anti-tumor functions: Implications in TIL therapy
Journal Articles

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

Available to Purchase
David M. Woods, Andressa L. Sodré, Alejandro Villagra, Amod Sarnaik, Eduardo M. Sotomayor, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (12): 1375–1385.
https://doi.org/10.1158/2326-6066.CIR-15-0077-T
Published: 06 December 2015
View articletitled, HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
Open the PDF for HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade in another window
Includes: Supplementary data
Journal Articles

Abstract PR09: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy

Free
Andressa Sodre Laino, David M. Woods, Esteban Celis, Jeffrey Weber, Eduardo Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): PR09.
https://doi.org/10.1158/2326-6074.TUMIMM14-PR09
Published: 09 October 2015
View articletitled, Abstract PR09: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy
Journal Articles

Abstract B19: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy

Free
Andressa Sodre Laino, David M. Woods, Esteban Celis, Jeffrey Weber, Eduardo Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): B19.
https://doi.org/10.1158/2326-6074.TUMIMM14-B19
Published: 09 October 2015
View articletitled, Abstract B19: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy